Congress Speakers

  • Itamar Raz, Israel | Congress Chairperson

    Itamar Raz, Israel | Congress Chairperson

    Itamar Raz, MD, received his medical degree from the Hadassah Hebrew University Medical School in Jerusalem in 1980. He is board certified in Internal Medicine, is a full professor of Internal Medicine and was the Head of the Diabetes Unit at Hadassah University Hospital 2000-2015...
    Read More..
  • Avivit Cahn, Israel

    Avivit Cahn, Israel

    Attending physician of the Diabetes Unit, division of internal medical, Hadassah Hebrew University hospital, Jerusalem
    Read More..
  • Antonio Ceriello, Spain

    Antonio Ceriello, Spain

    After earning his medical degree and specialty degree in diabetology and metabolic diseases at the University of Naples, Prof. Antonio Ceriello went on to hold a number of important research and professorship positions at prestigious scientific and academic institutions located in continental Europe, the U.S. and the U.K., ..
    Read More..
  • Ralph DeFronzo, USA

    Ralph DeFronzo, USA

    Ralph A. DeFronzo, MD, is Professor of Medicine and Chief of the Diabetes Division at the University of Texas Health Science Center and the Deputy Director of the Texas Diabetes Institute, San Antonio, Texas.  
    Read More..
  • Thomas Forst, Germany

    Thomas Forst, Germany

    March 2015 – until now
    Director Medical Sciences, Profil Institut für Stoffwechsel-forschung, Neuss

    March, 2013 - February 2015
    Chief Executive Operatator Profil Mainz GmbH, Mainz
    Read More..
  • Andreas Pfützner, Germany

    Andreas Pfützner, Germany

    Prof. Andreas Pfützner is Managing Director of the Pfützner Science & Health Institute, Diabetes Center & Practice in Mainz, Germany, focussing on insulin and insulin analogues, diabetes technology and medical device development. 
  • Helen Gao, USA

    Helen Gao, USA

    Helen Gao is a Senior Associate with Close Concerns, a diabetes and obesity information company based in San Francisco
    Read More..
  • Francesco Giorgino, Italy

    Francesco Giorgino, Italy

    Francesco Giorgino is Professor of Endocrinology and Metabolism, Chief of the Division of Endocrinology, and Director of the Department of Emergency and Organ Transplantation at the University of Bari Aldo Moro, Bari, Italy.
  • Ran Goshen, Israel

    Ran Goshen, Israel

    Ran serves as the Chief Medical Officer of Medial EarlySign.  Founded in 2009, Medial EarlySign applies advanced mathematical algorithms and artificial intelligence technology to detect early warning signals and health risks in simple medical data across billions of dormant medical records, spanning decades of information. 
    Read More..
  • Markolf Hanefeld, Germany

    Markolf Hanefeld, Germany

    Markolf Hanefeld, MD, Dr. hc. PhD is Professor of Internal Medicine, Endocrinology and Diabetology. 
    Read More..
  • Philip Home, UK

    Philip Home, UK

    Philip Home trained in medicine at Oxford University and Guy's Hospital, coming under the influence of Harry Keen, and thus gravitating into diabetes research. Continuing this research career in Newcastle upon Tyne, initially under the guidance of George Alberti, he has published over 390 papers ...
    Read More..
  • John Lachin, USA

    John Lachin, USA

    Dr. Lachin is Research Professor of Biostatistics and Epidemiology, and of Statistics, formerly with tenure 1987-2014; and formerly served as Director of The Biostatistics Center , a major research facility, 1998-2000.
    Read More..
  • Hiddo Lambers Heerspink, Netherlands

    Hiddo Lambers Heerspink, Netherlands

    Doctor Hiddo Lambers Heerspink is affiliated with the Department of Clinical Pharmacy and Pharmacology of the University Medical Center Groningen, the Netherlands.
    Read More..
  • Payal Marathe, USA

    Payal Marathe, USA

    Payal Marathe is a senior associate at Close Concerns, a San Francisco-based healthcare information company focused on diabetes and obesity. The Close Concerns team, led by president and founder Kelly Close, publishes Closer Look, a newsletter covering the latest news and insights related to these two chronic conditions.
    Read More..
  • James Nolan, USA

    James Nolan, USA

    Mr. Nolan has more than 25 years of experience in the life sciences industry, representing numerous major pharmaceutical companies
    Read More..
  • Paolo Pozzilli, Italy

    Paolo Pozzilli, Italy

    Paolo Pozzilli has received his Degree in Medicine and specialized in Endocrinology & Metabolic Diseases from University “Sapienza” of Rome, Italy. Since then he has worked mainly in the field of diabetes with particular focus into type 1 diabetes (T1D) pathogenesis and prevention in collaboration with several investigators around the world for more than 30 years. 
    Read More..
  • Neda Rasouli, USA

    Neda Rasouli, USA

    Dr. Rasouli received her MD degree from Tehran University of Medical Sciences, Iran and completed her Internal Medicine residency and Endocrinology fellowship trainings at Michigan State University and the University of Arkansas for Medical Sciences
    Read More..
  • Giuseppe M.C. Rosano, Italy

    Giuseppe M.C. Rosano, Italy

    After obtaining his MD in Medicine and Surgery, at the La Sapienza University of Rome with full honors in 1988, Giuseppe Rosano, obtained his specialisation in Cardiology in 1992, before attaining his PhD in Medical Sciences from the Imperial College in London. 
    Read More..
  • Oliver Schnell, Germany

    Oliver Schnell, Germany

    Oliver Schnell is a Professor at the Ludwig-Maximilians-University in Munich and at the Forschergruppe Diabetes e.V. Munich. He has received multiple national and international scientific awards and is also member of several guideline committees.
    Read More..
  • Eberhard Standl, Germany

    Eberhard Standl, Germany

    Dr. Eberhard Standl is a Professor of Medicine, specializing in endocrinology and angiology, at the Munich Diabetes Research Group e.V. at Helmholtz Centre. Dr. Standl's principal areas of research include diabetology, action and degradation of insulin and epidemiology of cardiovascular diabetic complications.
    Read More..